|
Q2 FY2027
As of Aug 31, 2026
|
Q1 FY2027
As of May 31, 2026
|
Q4 FY2026
As of Feb 28, 2026
|
Q3 FY2026
As of Nov 30, 2025
|
Q2 FY2026
As of Aug 31, 2025
|
Q1 FY2026
As of May 31, 2025
|
Q4 FY2025
As of Feb 28, 2025
|
Q3 FY2025
As of Nov 30, 2024
|
Q2 FY2025
As of Aug 31, 2024
|
Q1 FY2025
As of May 31, 2024
|
Q4 FY2024
As of Feb 29, 2024
|
Q3 FY2024
As of Nov 30, 2023
|
Q2 FY2024
As of Aug 31, 2023
|
Q1 FY2024
As of May 31, 2023
|
Q4 FY2023
As of Feb 28, 2023
|
Q3 FY2023
As of Nov 30, 2022
|
Q2 FY2023
As of Aug 31, 2022
|
Q1 FY2023
As of May 31, 2022
|
Q4 FY2022
As of Feb 28, 2022
|
Q3 FY2022
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaids | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Accrued liabilities - related party | ||||||||||||||||||||
| Due to an officer | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Stockholders' Deficit: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 50,000,000 shares authorized no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 500,000,000 shares authorized, 119,950,000 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | ||||||||||||||||||||
Loading...
